Diversity of Clinically Relevant Outcomes Resulting from Hypofractionated Radiation in Human Glioma Stem Cells Mirrors Distinct Patterns of Transcriptomic Changes
Hypofractionated radiotherapy is the mainstay of the current treatment for glioblastoma. However, the efficacy of radiotherapy is hindered by the high degree of radioresistance associated with glioma stem cells comprising a heterogeneous compartment of cell lineages differing in their phenotypic cha...
Main Authors: | Darius Kalasauskas, Maxim Sorokin, Bettina Sprang, Alhassan Elmasri, Sina Viehweg, Gabriela Salinas, Lennart Opitz, Margret Rave-Fraenk, Walter Schulz-Schaeffer, Sven Reiner Kantelhardt, Alf Giese, Anton Buzdin, Ella L. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/3/570 |
Similar Items
-
Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer
by: Carlo Greco
Published: (2013-09-01) -
Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01) -
Hypofractionation and prostate cancer: A good option for Africa?
by: Luca Incrocci, et al.
Published: (2017-08-01) -
Hypofractionated Radiotherapy in African Cancer Centers
by: William Swanson, et al.
Published: (2021-02-01) -
Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
by: Sean Mahase, et al.
Published: (2020-12-01)